AstraZeneca ups sales outlook again after strong third quarter
INSUBCONTINENT EXCLUSIVE:
New cancer treatments and an impressive emerging markets performance has helped drugs giant AstraZeneca hike its full-year sales outlook
for the second quarter running.
